AstraZeneca steps up China push with new drug joint venture

The stand-alone business, Dizal Pharmaceutical, will be owned equally with the Chinese Future Industry Investment Fund (FIIF), which is part-owned by the China State Development & Investment Corporation, the companies said on Monday. By getting into bed …
( read original story …)